Covaxx

About:

Covaxx is a biotech company developing diagnostic tests and vaccines designed to cure COVID-19.

Top Investors: Ministry of Health and Welfare (Taiwan)

Description:

Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity's Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.

Total Funding Amount:

$32.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Hauppauge, New York, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)covaxx.com

Founders:

Lou Reese, Mei Mei Hu, Peter Diamandis, Wang Changyi

Number of Employees:

11-50

Last Funding Date:

2020-08-07

IPO Status:

Private

Industries: